Asset
DEXMETHYLPHENIDATE
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04138498 | phase1_2 | completed | 2019-12-06 | 2020-03-06 | Cingulate Therapeutics | CTx-1301 Comparative Bioavailability Study |
| NCT04449250 | phase1 | completed | 2022-09-14 | 2022-10-14 | Cingulate Therapeutics | Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects |
| NCT07119073 | phase1 | completed | 2024-10-31 | 2024-12-21 | Cingulate Therapeutics | In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted) |
FDA applications (0)
This company has no applications containing this asset.